APOLLO HOSPITALS
and innovation : “ Apollo is the first healthcare organisation to realise that it couldn ’ t standardise multiple hospitals and patient services without the use of new technology . Hence embedding technology innovation and bench to bedside research into Apollo ’ s ecosystem is of paramount importance to us . These are cornerstones of a consistently evolving patient centric healthcare system .”
Apollo has introduced many cuttingedge initiatives - assessment of one`s genetic predisposition is one such step to personalising healthcare for an individual . Apollo has introduced a genetic predisposition test as part of its personalised health checks ( PHC ) - a single test to analyse and assess unique DNA makeup of the patient to find out what conditions they are more prone to . Genetic predisposition DNA tests can be carried out for over 60 conditions including cardiovascular , diabetes , and cancer . By monitoring a patient ’ s pre-disposition and combining it with their current clinical assessment , physicians can personalise advice given to a patient
in terms of their diet , exercise , general lifestyle , the frequency of specific tests and doctor consultations so as to stay healthy . “ For example , if someone is highly predisposed to cardiovascular disease and their clinical assessment is on the borderline , the physician can proactively monitor a patient`s lipid profile ,” says Mr Seemant Jauhari , CEO of Apollo Research & Innovations ( ARI ), who explains that “ it ’ s about staying more aware about one`s health and staying healthy ”. Currently , Apollo undertakes almost 200,000 PHC tests annually .
Another revolutionary initiative was
80 August 2017